Pretesh Patel, MD
Radiation Oncology · Durham, NCNPI 1750543807
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $7,300 of the $11,188 with a category attached, or 65.2%. Merck accounts for 62.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $7,895 and has fallen 97.4% since, to $202 in 2025. Among radiation oncology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 34 payments — averaging $329.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$7K
- Varian Medical Systems, Inc.$2K
- Stryker$1K
- Bard Peripheral Vascular, Inc.$550
- Siemens Medical Solutions USA, Inc.$406
- Blue Earth Diagnostics$255
- plus $239 from 3 others
What the payments were for
- Consulting fees$1,30012%
- Speaking & faculty fees$7,30065%
- Travel & lodging$6155%
- Food & beverage$1,97318%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 2 | $7,034 |
| Varian Medical Systems, Inc. | 3 | $1,532 |
| Stryker | 17 | $1,171 |
| Bard Peripheral Vascular, Inc. | 1 | $550 |
| Siemens Medical Solutions USA, Inc. | 3 | $406 |
| Blue Earth Diagnostics | 3 | $255 |
| Boston Scientific | 3 | $198 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Virtus Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,188 in reported general payments places this provider in the 90th percentile of 199 radiation oncology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 13 | $33,909 |
| Tamsulosin Hcl | 196 | $2,360 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $577 |
| Bicalutamide | 24 | $401 |
| Finasteride | 54 | $333 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $219 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $177 |
| Ciprofloxacin Hcl | 37 | $83 |
| Ibuprofen | 15 | $31 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 18 | $15 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Durham
- Lewis SulmanDurham$54K
- William LeeDurham$37K
- John KirkpatrickDurham$29K
- Brian CzitoDurham$28K
- David BrizelDurham$18K
- Christopher WillettDurham$8K
- Junzo ChinoDurham$3K
- Manisha PaltaDurham$3K
- Eugene VaiosDurham$2K
- Zachary ReitmanDurham$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.